Rivaroxaban Market, Global Outlook and Forecast 2023-2029

Rivaroxaban is an oral anticoagulant invented and manufactured by Bayer; in a number of countries it is marketed as Xarelto. In the United States, it is marketed by Janssen Pharmaceutica. It is the first available orally active direct factor Xa inhibitor. Rivaroxaban is well absorbed from the gut and maximum inhibition of factor Xa occurs four hours after a dose. The effects last approximately 8ﾖ12 hours, but factor Xa activity does not return to normal within 24 hours so once-daily dosing is possible.
This report aims to provide a comprehensive presentation of the global market for Rivaroxaban, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rivaroxaban. This report contains market size and forecasts of Rivaroxaban in global, including the following market information:
Global Rivaroxaban Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Rivaroxaban Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Rivaroxaban companies in 2022 (%)
The global Rivaroxaban market was valued at US$ 8226.5 million in 2022 and is projected to reach US$ 13960 million by 2029, at a CAGR of 7.8% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The major players in global Prom Dresses market include Bayer, Johnson and Johnson, etc. The top 2 players occupy nearly 100% of the market. Europe is the main market, and occupies nearly 100% of the global market. 10 mg is the main type, with a share over 30%. Venous Thromboembolism (VTE) is the main application, which holds a share about 85%.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Rivaroxaban manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Rivaroxaban Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Rivaroxaban Market Segment Percentages, by Type, 2022 (%)
    2.5 mg
    10 mg
    15 mg
    20 mg
Global Rivaroxaban Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Rivaroxaban Market Segment Percentages, by Application, 2022 (%)
    Acute Coronary Syndrome (ACS)
    Venous Thromboembolism (VTE)
Global Rivaroxaban Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Rivaroxaban Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Rivaroxaban revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Rivaroxaban revenues share in global market, 2022 (%)
Key companies Rivaroxaban sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Rivaroxaban sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Bayer
    J&J
Outline of Major Chapters:
Chapter 1: Introduces the definition of Rivaroxaban, market overview.
Chapter 2: Global Rivaroxaban market size in revenue and volume.
Chapter 3: Detailed analysis of Rivaroxaban manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Rivaroxaban in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Rivaroxaban capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.